The Difficult Task of Diagnosing Prostate Cancer Metastases on Dry Bone

被引:11
|
作者
Castoldi, Elisa [1 ]
Cappella, Annalisa [1 ]
Gibelli, Daniele [1 ]
Sforza, Chiarella [2 ]
Cattaneo, Cristina [1 ]
机构
[1] Univ Milan, Dipartimento Sci Biomed Salute, LABANOF Lab Antropol & Odontol Forense, Sez Med Legale, Via Luigi Mangiagalli 37, I-20133 Milan, Italy
[2] Univ Milan, Dipartimento Sci Biomed Salute, Via Luigi Mangiagalli 31, I-20133 Milan, Italy
关键词
forensic science; forensic anthropology; bone metastases; prostate cancer; identification; skeletal pathology; CARCINOMA; GROWTH;
D O I
10.1111/1556-4029.13617
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
The interpretation of pathology on skeletal remains is mandatory for implementing the biological profile and for disease recognition. Prostate cancer is one of the most common tumors, with a high preference for the skeleton as a primary site of metastasis. Its diagnosis on bone is however still ambiguous, due to its osteoblastic and resorptive manifestation. This study investigates distribution and appearance of prostate cancer metastases on dry bone on six known cases (selected from the Milano Cemetery Skeletal Collection) and one healthy individual. A macroscopic inspection was performed highlighting the abnormalities observed, describing location, shape, dimension, and aspect. A great amount of proliferative and mixed lesions was noticed, but also cases of pure lytic lesions were displayed. The multiple appearances of the manifestations observed display the difficulty in correctly identifying such a pathology, but also the potential and advantages provided by investigating a study sample with known antemortem history.
引用
收藏
页码:672 / 682
页数:11
相关论文
共 50 条
  • [31] Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases
    Nieder, Carsten
    Haukland, Ellinor
    Pawinski, Adam
    Dalhaug, Astrid
    BMC CANCER, 2010, 10
  • [32] Targeted α-Particle Therapy of Bone Metastases in Prostate Cancer
    Jadvar, Hossein
    Quinn, David I.
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (12) : 966 - 971
  • [33] Risk factors for the development of bone metastases in prostate cancer
    Petrylak, Daniel P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (11) : 677 - 682
  • [34] Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases
    Carsten Nieder
    Ellinor Haukland
    Adam Pawinski
    Astrid Dalhaug
    BMC Cancer, 10
  • [35] ETA antagonists in prostate cancer and the relationship to bone metastases
    Nelson, JB
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 : P2 - P2
  • [36] Survival markers related to bone metastases in prostate cancer
    Salminen, E. K.
    Kallioinen, M. J.
    Ala-Houhala, M. A.
    Vihinen, P. P.
    Tiitinen, S. L.
    Varpula, M.
    Vahlberg, T. J.
    ANTICANCER RESEARCH, 2006, 26 (6C) : 4879 - 4884
  • [37] Treatment strategy for prostate cancer patients with bone metastases
    Suzuki, Hiroyoshi
    Kato, Seiji
    Wakai, Ken
    Fang-ching, Lee
    Oka, Ryo
    Nishimi, Daisuke
    Endo, Takumi
    Yano, Masashi
    Kamijima, Shuichi
    Kamiya, Naoto
    ANNALS OF ONCOLOGY, 2017, 28 : 33 - 33
  • [38] Prognostic indicators for bone metastases in men with prostate cancer
    Rezvani, B.
    Yu, E.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 226 - 226
  • [39] Pathogenesis of Osteoblastic Bone Metastases From Prostate Cancer
    Ibrahim, Toni
    Flamini, Emanuela
    Mercatali, Laura
    Sacanna, Emanuele
    Serra, Patrizia
    Amadori, Dino
    CANCER, 2010, 116 (06) : 1406 - 1418
  • [40] Bisphosphonates in the treatment of bone metastases in prostate cancer (PCA).
    Voreuther, R
    Heidenreich, A
    Engelmann, UH
    JOURNAL OF UROLOGY, 1998, 159 (05): : 335 - 335